BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 33711555)

  • 21. The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
    Mandøe MJ; Hansen KB; Hartmann B; Rehfeld JF; Holst JJ; Hansen HS
    Am J Clin Nutr; 2015 Sep; 102(3):548-55. PubMed ID: 26178726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
    Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
    Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors and effects of gut hormones in three osteoblastic cell lines.
    Pacheco-Pantoja EL; Ranganath LR; Gallagher JA; Wilson PJ; Fraser WD
    BMC Physiol; 2011 Jul; 11():12. PubMed ID: 21801348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
    Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
    Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.
    Habib AM; Richards P; Rogers GJ; Reimann F; Gribble FM
    Diabetologia; 2013 Jun; 56(6):1413-6. PubMed ID: 23519462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
    Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; Nøhr MK; Egerod KL; Nawrocki AR; Kowalski T; Howard AD; Poulsen SS; Offermanns S; Bäckhed F; Holst JJ; Holst B; Schwartz TW
    Endocrinology; 2016 Jan; 157(1):176-94. PubMed ID: 26469136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.
    Pais R; Rievaj J; Meek C; De Costa G; Jayamaha S; Alexander RT; Reimann F; Gribble F
    J Physiol; 2016 Sep; 594(17):4865-78. PubMed ID: 27037495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
    Nunez DJ; Bush MA; Collins DA; McMullen SL; Gillmor D; Apseloff G; Atiee G; Corsino L; Morrow L; Feldman PL
    PLoS One; 2014; 9(4):e92494. PubMed ID: 24699248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
    Boland BB; Mumphrey MB; Hao Z; Townsend RL; Gill B; Oldham S; Will S; Morrison CD; Yu S; Münzberg H; Rhodes CJ; Trevaskis JL; Berthoud HR
    Mol Metab; 2019 Jul; 25():64-72. PubMed ID: 31126840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA; Finan B; Gelfanov V; Yang B; Tschöp MH; DiMarchi RD; Perez-Tilve D
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.
    Joshi S; Tough IR; Cox HM
    Br J Pharmacol; 2013 Nov; 170(5):1092-101. PubMed ID: 23992397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of Gut Hormones and Expression of Sweet Taste Receptors and Glucose Transporters in a Rat Model of Obesity.
    Feng RL; Qian C; Liu LY; Liu QJ; Jin YQ; Li SX; Liu W; Rayner CK; Ma J
    Obes Facts; 2019; 12(2):190-198. PubMed ID: 30928977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety.
    Brooks L; Viardot A; Tsakmaki A; Stolarczyk E; Howard JK; Cani PD; Everard A; Sleeth ML; Psichas A; Anastasovskaj J; Bell JD; Bell-Anderson K; Mackay CR; Ghatei MA; Bloom SR; Frost G; Bewick GA
    Mol Metab; 2017 Jan; 6(1):48-60. PubMed ID: 28123937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct adaptations of endocrine and cognitive functions may contribute to high variability in long-term weight loss outcome after bariatric surgery.
    Lammert M; Medawar E; Hartmann H; Grasser L; Dietrich A; Fenske W; Horstmann A
    Physiol Behav; 2023 Oct; 269():114279. PubMed ID: 37356514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementation of oligofructose, but not sucralose, decreases high-fat diet induced body weight gain in mice independent of gustducin-mediated gut hormone release.
    Steensels S; Cools L; Avau B; Vancleef L; Farré R; Verbeke K; Depoortere I
    Mol Nutr Food Res; 2017 Mar; 61(3):. PubMed ID: 27800650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon.
    Modvig IM; Christiansen CB; Rehfeld JF; Holst JJ; Veedfald S
    Physiol Rep; 2020 Jan; 8(2):e14352. PubMed ID: 31984675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulating intestinal GIP release reduces food intake and body weight in mice.
    Lewis JE; Nuzzaci D; James-Okoro PP; Montaner M; O'Flaherty E; Darwish T; Hayashi M; Liberles SD; Hornigold D; Naylor J; Baker D; Gribble FM; Reimann F
    Mol Metab; 2024 Jun; 84():101945. PubMed ID: 38653401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.